Stereotaxis launches robotic magnetic navigation system and imaging system

Stereotaxis, a leader in robotic technologies for the treatment of cardiac arrhythmias, has introduced Stereotaxis Genesis RMN, a robotic platform that it claims is a significant advancement in robotic magnetic navigation technology.

The system provides the established benefits and reliability of robotic magnetic navigation in a highly innovative architecture that is faster, smaller, lighter and more flexible, says the company.

Since the original launch of the Niobe I system in 2003, improvements in Stereotaxis’ robotic system have remained iterative. Genesis RMN uses novel smaller magnets that rotate along their centre of mass and are held by flexible robotic arms.

This mechanism allows for instantaneous responsiveness to physician control and the flexibility to accommodate an increased range of motion.

The Genesis RMN system’s significant reduction in size provides physicians and nurses greater access to the patient during the procedure. The system represents a platform able to accommodate significant innovation in the future.

Stereotaxis Genesis RMN is being launched concurrently with Stereotaxis Imaging Model S as an integrated complete solution for a robotic interventional operating room.

Stereotaxis Imaging Model S is a single-plane full-power x-ray system designed to be specifically available with the Genesis RMN system. It includes the c-arm, powered table, motorised boom, and large high-definition monitors.

Developed in collaboration with Omega Medical Imaging, Stereotaxis Imaging incorporates modern fluoroscopy technology designed to support high quality imaging while minimising radiation exposure for patients and physicians.

The combination of Genesis RMN with Stereotaxis Imaging in a tightly integrated fashion significantly reduces the cost of acquisition, the ongoing cost of ownership, and the complexity of installation of a robotic electrophysiology practice.

“Dr. Natale and I had the opportunity to observe the Genesis and Stereotaxis Imaging systems in person,” said Dr. J. David Burkhardt, cardiac electrophysiologist, Texas Cardiac Arrhythmia Institute at St. David’s Medical Center.

“I consider this a significant and impressive leap forward, and am excited to see the positive impact of this innovation on patient care, procedure efficiency and the overall experience in the electrophysiology lab.”

Stereotaxis Genesis RMN is CE marked and available for commercialisation across various EU geographies. Availability in other global geographies is subject to regulatory approvals, which will be pursued in the coming months.

Stereotaxis Imaging Model S has FDA clearance, CE mark, and is commercially available in the US, EU and certain other global geographies. Stereotaxis Imaging Model S is compatible with Niobe.